141 related articles for article (PubMed ID: 19994585)
1. [The possibility of selective Rho-associated kinase (ROCK) inhibitors as a medical treatment for glaucoma].
Honjo M
Nippon Ganka Gakkai Zasshi; 2009 Nov; 113(11):1071-81. PubMed ID: 19994585
[TBL] [Abstract][Full Text] [Related]
2. Rho-associated kinase inhibitors: a novel glaucoma therapy.
Inoue T; Tanihara H
Prog Retin Eye Res; 2013 Nov; 37():1-12. PubMed ID: 23770081
[TBL] [Abstract][Full Text] [Related]
3. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
[TBL] [Abstract][Full Text] [Related]
4. Rho/Rho-associated kinase pathway in glaucoma (Review).
Wang J; Liu X; Zhong Y
Int J Oncol; 2013 Nov; 43(5):1357-67. PubMed ID: 24042317
[TBL] [Abstract][Full Text] [Related]
5. Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.
Honjo M; Tanihara H
Jpn J Ophthalmol; 2018 Mar; 62(2):109-126. PubMed ID: 29445943
[TBL] [Abstract][Full Text] [Related]
6. Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery.
Van de Velde S; Van Bergen T; Vandewalle E; Kindt N; Castermans K; Moons L; Stalmans I
Prog Brain Res; 2015; 220():283-97. PubMed ID: 26497796
[TBL] [Abstract][Full Text] [Related]
7. Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits.
Isobe T; Mizuno K; Kaneko Y; Ohta M; Koide T; Tanabe S
Curr Eye Res; 2014 Aug; 39(8):813-22. PubMed ID: 24502505
[TBL] [Abstract][Full Text] [Related]
8. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility.
Honjo M; Tanihara H; Inatani M; Kido N; Sawamura T; Yue BY; Narumiya S; Honda Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):137-44. PubMed ID: 11133858
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase inhibitors-a review on the physiology and clinical use in Ophthalmology.
Moura-Coelho N; Tavares Ferreira J; Bruxelas CP; Dutra-Medeiros M; Cunha JP; Pinto Proença R
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1101-1117. PubMed ID: 30843105
[TBL] [Abstract][Full Text] [Related]
10. Ocular hypotensive efficacy of Src-family tyrosine kinase inhibitors via different cellular actions from Rock inhibitors.
Kirihara T; Shimazaki A; Nakamura M; Miyawaki N
Exp Eye Res; 2014 Feb; 119():97-105. PubMed ID: 24321889
[TBL] [Abstract][Full Text] [Related]
11. AMA0076, a novel, locally acting Rho kinase inhibitor, potently lowers intraocular pressure in New Zealand white rabbits with minimal hyperemia.
Van de Velde S; Van Bergen T; Sijnave D; Hollanders K; Castermans K; Defert O; Leysen D; Vandewalle E; Moons L; Stalmans I
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1006-16. PubMed ID: 24474276
[TBL] [Abstract][Full Text] [Related]
12. Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration.
Schram K; Ganguly R; No EK; Fang X; Thong FS; Sweeney G
Endocrinology; 2011 May; 152(5):2037-47. PubMed ID: 21385940
[TBL] [Abstract][Full Text] [Related]
13. Rho kinase inhibitors for glaucoma treatment - Review.
Germano RA; Finzi S; Challa P; Susanna Junior R
Arq Bras Oftalmol; 2015; 78(6):388-91. PubMed ID: 26677046
[TBL] [Abstract][Full Text] [Related]
14. An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor.
Ibrahim DG; Ko JA; Iwata W; Okumichi H; Kiuchi Y
Cell Biochem Funct; 2019 Mar; 37(2):113-124. PubMed ID: 30773659
[TBL] [Abstract][Full Text] [Related]
15. Rho GTPase/Rho kinase inhibition as a novel target for the treatment of glaucoma.
Rao VP; Epstein DL
BioDrugs; 2007; 21(3):167-77. PubMed ID: 17516712
[TBL] [Abstract][Full Text] [Related]
16. Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts.
Akhmetshina A; Dees C; Pileckyte M; Szucs G; Spriewald BM; Zwerina J; Distler O; Schett G; Distler JH
Arthritis Rheum; 2008 Aug; 58(8):2553-64. PubMed ID: 18668558
[TBL] [Abstract][Full Text] [Related]
17. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
Meyer-ter-Vehn T; Sieprath S; Katzenberger B; Gebhardt S; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4895-904. PubMed ID: 17065504
[TBL] [Abstract][Full Text] [Related]
18. Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma.
Inoue T; Tanihara H
Expert Opin Pharmacother; 2017 Oct; 18(15):1669-1673. PubMed ID: 28893104
[TBL] [Abstract][Full Text] [Related]
19. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
Rao PV; Deng PF; Kumar J; Epstein DL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
[TBL] [Abstract][Full Text] [Related]
20. Rho-kinase inhibitors in the management of glaucoma.
Berrino E; Supuran CT
Expert Opin Ther Pat; 2019 Oct; 29(10):817-827. PubMed ID: 31573364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
